-
Product Insights
Myelofibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Myelofibrosis - Drugs In Development, 2023’, provides an overview of the Myelofibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myelofibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Company Insights
Bayer AG – Digital Transformation Strategies
Bayer implemented a five-year global IT strategy to drive its digital business transformation by aligning itself to emerging technologies like cloud, IoT, and AI among others. The annual ICT spending of Bayer was estimated at $2.3 billion in 2022. A major share of this spending is earmarked for acquiring hardware, network and communications, and software from vendors. Bayer is a life science company engaged in research, development, manufacture, and supply of products in healthcare and agriculture. Total ICT Spending 2022...
-
Product Insights
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-Small Cell Lung Cancer Pipeline Drugs Market Report Overview Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. NSCLC is a cancer (malignancy) that originates in the tissues of the lungs or the cells lining the airways. Symptoms of lung cancer usually occur in the later stages of the disease. The signs and symptoms include a persistent cough that may get worse over time, trouble breathing or shortness of breath, constant chest pain or discomfort, bloody...
-
Product Insights
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Head and Neck Cancer Pipeline Drugs Market Report Overview Head and Neck Cancer symptoms include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. Treatment includes chemotherapy and radiation therapy. The Head and Neck Cancer pipeline drugs market research report provides an analysis of the Head and Neck Cancer drugs by stage of development, drug target, mechanism of action (MoA), route...
-
Thematic Analysis
Artificial Intelligence (AI) in Drug Discovery Market – Thematic Research
Explore trends and insights from the following data in the ‘Artificial Intelligence (AI) in Drug Discovery Market’ thematic report: Understanding the key trends impacting the theme over the next 12 to 24 months. Comprehensive analysis of drugs discovered using AI and survey data on the adoption of AI in pharma. Detailed value chain breaks down Artificial Intelligence (AI) in the Drug Discovery Market into Target Identification and Validation, Generation of Molecule Leads/De Novo Drug Design, Drug Repurposing, and Response Biomarker...
-
Product Insights
Alzheimer’s Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Alzheimer’s Disease Drugs Development Report Overview Alzheimer's disease is a progressive, degenerative condition causing damage to memory and behavior due to the attack on the neurons. Predisposing factors include age, heredity, cardiovascular diseases or diabetes, and environmental factors. Symptoms include depression, anxiety, social withdrawal, irritability, and aggressiveness. Buy the Full Report for More Insights on the Alzheimer’s Disease Drugs in Development Report, Download a Free Sample The Alzheimer’s Disease Drugs in Development market research report provides an overview of the...
-
Company Insights
Enterprise Tech Ecosystem Series – Bayer AG
Bayer AG (Bayer), headquartered at Germany, is a life science company engaged in research, development, manufacture, and supply of products for healthcare and agriculture.
-
Sector Analysis
Canada In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.
GlobalData’s “Canada In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Canada In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The Canada In Vitro Diagnostics Market report provides key information and data on: • Annualized market revenues (USD), volume...